RhoB loss induces Rac1-dependent mesenchymal cell invasion in lung cells through PP2A inhibition

Emilie Bousquet, Olivier Calvayrac, Julien Mazières, +4

Oncogene

Lung CellsCell RegulationTumor MicroenvironmentLung InflammationMedicine +9

Loss of RhoB Expression Promotes Migration and Invasion of Human Bronchial Cells Via Activation of AKT1

Emilie Bousquet, Julien Mazières, Maud Privat, +7

Cancer Research

Lung Cancer ProgressionImmunologyCancer BiologyCellular PhysiologyTumor Biology +15

An oligoclonal antibody durably overcomes resistance of lung cancer to third‐generation <scp>EGFR</scp> inhibitors

Maicol Mancini, Hilah Gal, Nadège Gaborit, +17

EMBO Molecular Medicine

Incidence of thyroid dysfunctions during treatment with nivolumab for non-small cell lung cancer: Retrospective study of 105 patients

Pauline Campredon, C. Mouly, Amélie Lusque, +4

La Presse Médicale

Retrospective StudyThyroid DysfunctionsOncologyThyroid DiseaseCancer Treatment +4

Tolerance and acceptability of 14 surgical and hygienic alcohol-based hand rubs

R. Girard, Emilie Bousquet, E. Carré, +7

Journal of Hospital Infection

Hand TraumaWound HealingHand SurgeryDermatologyMedicine +2

The <scp>RAS</scp> ‐related <scp>GTP</scp> ase <scp>RHOB</scp> confers resistance to <scp>EGFR</scp> ‐tyrosine kinase inhibitors in non‐small‐cell lung cancer via an <scp>AKT</scp> ‐dependent mechanism

Olivier Calvayrac, Julien Mazières, Sarah Figarol, +14

EMBO Molecular Medicine

RhoB Determines Tumor Aggressiveness in a Murine EGFRL858R-Induced Adenocarcinoma Model and Is a Potential Prognostic Biomarker for Lepidic Lung Cancer

Olivier Calvayrac, Anne Pradines, Isabelle Raymond‐Letron, +10

Clinical Cancer Research

The evolution of resistance and tolerance as cancer defences

Frédéric Thomas, Mathieu Giraudeau, Flora Gouzerh, +12

Parasitology

Health SciencesTumor HeterogeneityMedicineOncogenic AgentNatural Defences +12

Development of a conditional bioluminescent transplant model for TPM3-ALK-induced tumorigenesis as a tool to validate ALK-dependent cancer targeted therapy

Sylvie Giuriato, Nathalie Faumont, Emilie Bousquet, +7

Cancer Biology & Therapy

ImmunologyTumor BiologyReversible Tpm3-alk ExpressionTransplant ModelOncology +14

Development of Papulopustular Rosacea during Nivolumab Therapy for Metastatic Cancer

Emilie Bousquet, Allison Zarbo, É. Tournier, +4

Acta Dermato Venereologica